David F. Jarrard - Publications

University of Wisconsin, Madison, Madison, WI 
Molecular Biology, Oncology

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Rutkowski DR, Wells SA, Johnson B, Huang W, Jarrard DF, Lang JM, Cho S, Roldán-Alzate A. Mri-based cancer lesion analysis with 3d printed patient specific prostate cutting guides. American Journal of Clinical and Experimental Urology. 7: 215-222. PMID 31511828  0.32
2019 Yu J, Berthier E, Craig A, de Groot TE, Sparks S, Ingram PN, Jarrard DF, Huang W, Beebe DJ, Theberge AB. Reconfigurable open microfluidics for studying the spatiotemporal dynamics of paracrine signalling. Nature Biomedical Engineering. PMID 31427781 DOI: 10.1038/s41551-019-0421-4  0.32
2019 Etheridge T, Damodaran S, Schultz A, Richards KA, Gawdzik J, Yang B, Cryns V, Jarrard DF. Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier. Asian Journal of Urology. 6: 57-64. PMID 30775249 DOI: 10.1016/j.ajur.2018.09.001  0.32
2018 Etheridge T, Straus J, Ritter MA, Jarrard DF, Huang W. Semen AMACR protein as a novel method for detecting prostate cancer. Urologic Oncology. PMID 30337219 DOI: 10.1016/j.urolonc.2018.09.010  0.32
2018 Spiniello M, Knoener RA, Steinbrink MI, Yang B, Cesnik AJ, Buxton KE, Scalf M, Jarrard DF, Smith LM. HyPR-MS for multiplexed discovery of MALAT1, NEAT1, and NORAD lncRNA protein interactomes. Journal of Proteome Research. PMID 29972301 DOI: 10.1021/acs.jproteome.8b00189  0.32
2018 Cesnik AJ, Yang B, Truong A, Etheridge T, Spiniello M, Steinbrink MI, Shortreed MR, Frey BL, Jarrard DF, Smith LM. Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate Cancers. Translational Oncology. 11: 808-814. PMID 29723810 DOI: 10.1016/j.tranon.2018.04.002  0.32
2018 Johnson BP, Vitek RA, Geiger PG, Huang W, Jarrard DF, Lang JM, Beebe DJ. Vital ex vivo tissue labeling and pathology-guided micropunching to characterize cellular heterogeneity in the tissue microenvironment. Biotechniques. 64: 13-19. PMID 29384072 DOI: 10.2144/000114626  0.32
2017 Lee JH, Yang B, Lindahl AJ, Damaschke N, Boersma MD, Huang W, Corey E, Jarrard DF, Denu JM. Identifying dysregulated epigenetic enzyme activity in castrate-resistant prostate cancer development. Acs Chemical Biology. PMID 28949514 DOI: 10.1021/acschembio.6b01035  0.32
2017 Damaschke N, Yang B, Bhusari S, Avilla M, Zhong W, Blute ML, Huang W, Jarrard DF. Loss of IGF2 gene imprinting in murine prostate promotes widespread neoplastic growth. Cancer Research. PMID 28775169 DOI: 10.1158/0008-5472.CAN-16-3089  0.32
2017 Blute ML, Damaschke N, Wagner J, Yang B, Gleave M, Fazli L, Shi F, Abel EJ, Downs TM, Huang W, Jarrard DF. Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy. Plos One. 12: e0172048. PMID 28234906 DOI: 10.1371/journal.pone.0172048  0.32
2016 Heninger E, Krueger TE, Thiede SM, Sperger JM, Byers BL, Kircher MR, Kosoff D, Yang B, Jarrard DF, McNeel DG, Lang JM. Inducible expression of cancer-testis antigens in human prostate cancer. Oncotarget. PMID 27769045 DOI: 10.18632/oncotarget.12711  0.32
2015 Jarrard DF, Huang W. The New Age of Molecular Taxonomy Approaches. European Urology. PMID 26626616 DOI: 10.1016/j.eururo.2015.11.011  0.36
2015 Blute ML, Zorn K, Grimes M, Shi F, Downs TM, Jarrard DF, Best SL, Richards K, Nakada SY, Abel EJ. Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer. Bju International. PMID 26589741 DOI: 10.1111/bju.13381  0.36
2015 Blute ML, Rushmer TJ, Shi F, Fuller B, Abel EJ, Jarrard DF, Downs TM. Renin-Angiotensin Inhibitors Decrease Recurrence After Turbt in Non-Muscle Invasive Bladder Cancer. The Journal of Urology. PMID 26173101 DOI: 10.1016/j.juro.2015.05.104  0.36
2015 Blute ML, Abel EJ, Downs TM, Kelcz F, Jarrard DF. Addressing the need for repeat prostate biopsy: New technology and approaches Nature Reviews Urology. 12: 435-444. PMID 26171803 DOI: 10.1038/nrurol.2015.159  0.36
2015 Abel EJ, Heckman JE, Hinshaw L, Best S, Lubner M, Jarrard DF, Downs TM, Nakada SY, Lee FT, Huang W, Ziemlewicz T. Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal Masses. The Journal of Urology. PMID 25837535 DOI: 10.1016/j.juro.2015.03.106  0.36
2014 Damaschke NA, Yang B, Blute ML, Lin CP, Huang W, Jarrard DF. Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer. Neoplasia (New York, N.Y.). 16: 1018-27. PMID 25499215 DOI: 10.1016/j.neo.2014.10.003  0.32
2014 Keil KP, Abler LL, Laporta J, Altmann HM, Yang B, Jarrard DF, Hernandez LL, Vezina CM. Androgen receptor DNA methylation regulates the timing and androgen sensitivity of mouse prostate ductal development. Developmental Biology. 396: 237-45. PMID 25446526 DOI: 10.1016/j.ydbio.2014.10.006  0.36
2014 Jarrard DF, Blute ML, Ritter MA. Potential role for androgen-deprivation therapy and pelvic radiation therapy in node-positive postprostatectomy prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3926-9. PMID 25332250 DOI: 10.1200/JCO.2014.57.8302  0.36
2014 Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? European Urology. 66: 1139-47. PMID 25194909 DOI: 10.1016/j.eururo.2014.08.051  0.36
2014 Abel EJ, Wong K, Sado M, Leverson GE, Patel SR, Downs TM, Jarrard DF. Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. Jsls : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. 18: 282-7. PMID 24960494 DOI: 10.4293/108680813X13693422518551  0.36
2014 Abel EJ, Bauman TM, Weiker M, Shi F, Downs TM, Jarrard DF, Huang W. Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression Human Pathology. 45: 1092-1099. PMID 24746216 DOI: 10.1016/j.humpath.2014.01.008  0.36
2014 Yang B, Wagner J, Damaschke N, Yao T, Wuerzberger-Davis SM, Lee MH, Svaren J, Miyamoto S, Jarrard DF. A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation. Plos One. 9: e88052. PMID 24558376 DOI: 10.1371/journal.pone.0088052  0.32
2013 Yang B, Wagner J, Yao T, Damaschke N, Jarrard DF. Pyrosequencing for the rapid and efficient quantification of allele-specific expression. Epigenetics. 8: 1039-42. PMID 23973940 DOI: 10.4161/epi.25892  0.32
2013 Yang B, Bhusari S, Kueck J, Weeratunga P, Wagner J, Leverson G, Huang W, Jarrard DF. Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer. Neoplasia (New York, N.Y.). 15: 399-408. PMID 23555185  0.32
2013 Truong M, Yang B, Wagner J, Desotelle J, Jarrard DF. Analysis of promoter non-CG methylation in prostate cancer. Epigenomics. 5: 65-71. PMID 23414321 DOI: 10.2217/epi.12.67  0.32
2013 Truong M, Yang B, Livermore A, Wagner J, Weeratunga P, Huang W, Dhir R, Nelson J, Lin DW, Jarrard DF. Using the epigenetic field defect to detect prostate cancer in biopsy negative patients. The Journal of Urology. 189: 2335-41. PMID 23159584 DOI: 10.1016/j.juro.2012.11.074  0.32
2013 Babaian K, Truong M, Cetnar J, Cross DS, Shi F, Ritter MA, Jarrard DF. Analysis of urological procedures in men who died from prostate cancer using a population-based approach. Bju International. 111: E65-70. PMID 23130676 DOI: 10.1111/j.1464-410X.2012.11517.x  0.36
2013 Truong M, Yang B, Jarrard DF. Toward the detection of prostate cancer in urine: a critical analysis. The Journal of Urology. 189: 422-9. PMID 23017522 DOI: 10.1016/j.juro.2012.04.143  0.32
2013 Ewald JA, Desotelle JA, Church DR, Yang B, Huang W, Laurila TA, Jarrard DF. Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo Prostate. 73: 337-345. PMID 22911222 DOI: 10.1002/pros.22571  0.36
2013 King AC, Livermore A, Laurila TA, Huang W, Jarrard DF. Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer. Urologic Oncology. 31: 739-43. PMID 21816639 DOI: 10.1016/j.urolonc.2011.06.011  0.36
2012 Ewald JA, Jarrard DF. Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer. Translational Oncology. 5: 278-87. PMID 22937180  0.32
2011 Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, et al. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prevention Research (Philadelphia, Pa.). 4: 1761-9. PMID 21896650 DOI: 10.1158/1940-6207.CAPR-10-0343  0.36
2011 Kruser TJ, Jarrard DF, Graf AK, Hedican SP, Paolone DR, Wegenke JD, Liu G, Geye HM, Ritter MA. Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence. Cancer. 117: 2629-36. PMID 21656740 DOI: 10.1002/cncr.25824  0.36
2011 Bhusari S, Yang B, Kueck J, Huang W, Jarrard DF. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer. The Prostate. 71: 1621-30. PMID 21432864 DOI: 10.1002/pros.21379  0.32
2010 Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. Journal of the National Cancer Institute. 102: 1536-46. PMID 20858887 DOI: 10.1093/jnci/djq364  0.36
2010 Quann P, Jarrard DF, Huang W. Current prostate biopsy protocols cannot reliably identify patients for focal therapy: correlation of low-risk prostate cancer on biopsy with radical prostatectomy findings. International Journal of Clinical and Experimental Pathology. 3: 401-7. PMID 20490330  0.32
2010 Bhusari SS, Dobosy JR, Fu V, Almassi N, Oberley T, Jarrard DF. Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate. Epigenetics : Official Journal of the Dna Methylation Society. 5: 402-9. PMID 20458166  0.36
2010 Iskandar BJ, Rizk E, Meier B, Hariharan N, Bottiglieri T, Finnell RH, Jarrard DF, Banerjee RV, Skene JH, Nelson A, Patel N, Gherasim C, Simon K, Cook TD, Hogan KJ. Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation. The Journal of Clinical Investigation. 120: 1603-16. PMID 20424322 DOI: 10.1172/JCI40000  0.36
2009 Ewald JA, Peters N, Desotelle JA, Hoffmann FM, Jarrard DF. A high-throughput method to identify novel senescence-inducing compounds. Journal of Biomolecular Screening. 14: 853-8. PMID 19641224 DOI: 10.1177/1087057109340314  0.36
2009 Laurila TA, Huang W, Jarrard DF. Robotic-assisted laparoscopic and radical retropubic prostatectomy generate similar positive margin rates in low and intermediate risk patients. Urologic Oncology. 27: 529-33. PMID 18640061 DOI: 10.1016/j.urolonc.2008.05.001  0.32
2008 Fu VX, Dobosy JR, Desotelle JA, Almassi N, Ewald JA, Srinivasan R, Berres M, Svaren J, Weindruch R, Jarrard DF. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. Cancer Research. 68: 6797-802. PMID 18701505 DOI: 10.1158/0008-5472.CAN-08-1714  0.36
2008 Dobosy JR, Fu VX, Desotelle JA, Srinivasan R, Kenowski ML, Almassi N, Weindruch R, Svaren J, Jarrard DF. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate. The Prostate. 68: 1187-95. PMID 18459101 DOI: 10.1002/pros.20782  0.36
2008 Wong GW, Palazzi-Churas KL, Jarrard DF, Paolone DR, Graf AK, Hedican SP, Wegenke JD, Ritter MA. Salvage Hypofractionated Radiotherapy for Biochemically Recurrent Prostate Cancer After Radical Prostatectomy International Journal of Radiation Oncology Biology Physics. 70: 449-455. PMID 17869014 DOI: 10.1016/j.ijrobp.2007.06.042  0.36
2007 Best S, Sawers Y, Fu VX, Almassi N, Huang W, Jarrard DF. Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy. Urology. 70: 328-32. PMID 17826499 DOI: 10.1016/j.urology.2007.04.005  0.36
2007 Allen GW, Howard AR, Jarrard DF, Ritter MA. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Cancer. 110: 1405-16. PMID 17685384 DOI: 10.1002/cncr.22940  0.36
2007 Kibel AS, Rosenbaum E, Kattan MW, Picus J, Dreicer R, Klein EA, Chatta GS, Nelson JB, DiPaola RS, Roth BJ, Cookson MS, Wilding G, Jarrard DF, Beer TM, Ryan CW, et al. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. The Journal of Urology. 177: 1777-81. PMID 17437819 DOI: 10.1016/j.juro.2007.01.028  0.36
2007 Katz DA, Jarrard DF, McHorney CA, Hillis SL, Wiebe DA, Fryback DG. Health perceptions in patients who undergo screening and workup for prostate cancer. Urology. 69: 215-20. PMID 17320653 DOI: 10.1016/j.urology.2006.09.059  0.36
2007 Dobosy JR, Roberts JL, Fu VX, Jarrard DF. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. The Journal of Urology. 177: 822-31. PMID 17296351 DOI: 10.1016/j.juro.2006.10.063  0.36
2006 Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Molecular Cancer Therapeutics. 5: 1335-41. PMID 16731767 DOI: 10.1158/1535-7163.MCT-05-0526  0.36
2005 Schwarze SR, Fu VX, Desotelle JA, Kenowski ML, Jarrard DF. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia (New York, N.Y.). 7: 816-23. PMID 16229804 DOI: 10.1593/neo.05250  0.36
2005 Wilkin M, Horwitz G, Seetharam A, Hartenbach E, Schink JC, Bruskewitz R, Jarrard DF. Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation Urologic Oncology: Seminars and Original Investigations. 23: 12-15. PMID 15885577 DOI: 10.1016/j.urolonc.2004.07.018  0.36
2005 Faith D, Han S, Lee DK, Friedl A, Hicks JL, De Marzo AM, Jarrard DF. p16 is upregulated in proliferative inflammatory atrophy of the prostate Prostate. 65: 73-82. PMID 15880529 DOI: 10.1002/pros.20258  0.36
2005 Schwarze SR, Luo J, Isaacs WB, Jarrard DF. Modulation of CXCL14 (BRAK) expression in prostate cancer. The Prostate. 64: 67-74. PMID 15651028 DOI: 10.1002/pros.20215  0.36
2004 Fu VX, Schwarze SR, Kenowski ML, Leblanc S, Svaren J, Jarrard DF. A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells. The Journal of Biological Chemistry. 279: 52218-26. PMID 15471867 DOI: 10.1074/jbc.M405015200  0.36
2003 Atwood CS, Barzilai N, Bowen RL, Brown-Borg HM, Jarrard DF, Fu VX, Heilbronn LK, Ingram DK, Ravussin E, Schwartz RS, Weindruch R. Pennington scientific symposium on mechanisms and retardation of aging. Experimental Gerontology. 38: 1217-26. PMID 14580876 DOI: 10.1016/j.exger.2003.08.005  0.36
2003 Schwarze SR, Fu VX, Jarrard DF. Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival. Cancer Research. 63: 4614-9. PMID 12907640  0.36
2002 Jarrard DF, Modder J, Fadden P, Fu V, Sebree L, Heisey D, Schwarze SR, Friedl A. Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer. Cancer Letters. 185: 191-9. PMID 12169393 DOI: 10.1016/S0304-3835(02)00282-3  0.36
2002 Schwarze SR, DePrimo SE, Grabert LM, Fu VX, Brooks JD, Jarrard DF. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. The Journal of Biological Chemistry. 277: 14877-83. PMID 11836256 DOI: 10.1074/jbc.M200373200  0.36
Show low-probability matches.